TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 122 filers reported holding TRANSMEDICS GROUP INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,151,585 | +20.0% | 61,343 | +8.2% | 0.02% | +19.0% |
| Q1 2023 | $4,294,195 | +15.5% | 56,704 | -5.9% | 0.02% | +23.5% |
| Q4 2022 | $3,717,519 | +35.5% | 60,232 | -8.4% | 0.02% | +30.8% |
| Q3 2022 | $2,744,000 | -29.8% | 65,730 | -44.4% | 0.01% | -23.5% |
| Q3 2021 | $3,910,000 | – | 118,141 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 923,221 | $30,632,000 | 5.64% |
| Sandhill Capital Partners LLC | 1,429,432 | $47,429,000 | 3.70% |
| Bullseye Asset Management LLC | 117,471 | $3,898,000 | 1.31% |
| Taylor Wealth Management Partners | 72,685 | $2,412,000 | 0.85% |
| Signature Wealth Management Partners, LLC | 14,000 | $465,000 | 0.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 369,259 | $12,252,000 | 0.40% |
| Triumph Capital Management | 20,051 | $622,000 | 0.36% |
| EMERALD ADVISERS, LLC | 300,464 | $9,969,000 | 0.36% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,347 | $2,533,000 | 0.30% |
| Bellevue Group AG | 729,989 | $24,221,000 | 0.24% |